ANI Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. ANI Pharmaceuticals shares (ANIP) are listed on the NASDAQ and all prices are listed in US Dollars. ANI Pharmaceuticals employs 369 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in ANI Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANIP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ANIP shares summary
- Compare share dealing platforms
- Is ANIP stock a buy or sell?
- Stock performance over time
- Can I short ANIP shares?
- Are ANIP shares over-valued?
- ANI Pharmaceuticals's financials
- How volatile are ANIP shares?
- Does ANI Pharmaceuticals pay a dividend?
- Have ANIP shares ever split?
- Other common questions
ANI Pharmaceuticals stock price (NASDAQ: ANIP)Use our graph to track the performance of ANIP stocks over time.
ANI Pharmaceuticals shares at a glance
|Latest market close||$34.35|
|52-week range||$23.55 - $40.00|
|50-day moving average||$33.87|
|200-day moving average||$32.78|
|Wall St. target price||$45.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.34|
Buy ANI Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ANI Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ANI Pharmaceuticals price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||3.96%|
|3 months (2021-04-26)||4.69%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Is ANI Pharmaceuticals under- or over-valued?
Valuing ANI Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ANI Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ANI Pharmaceuticals's PEG ratio
ANI Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.06. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ANI Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ANI Pharmaceuticals's EBITDA
ANI Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $50.7 million.
The EBITDA is a measure of a ANI Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
ANI Pharmaceuticals financials
|Revenue TTM||$213.2 million|
|Operating margin TTM||2.96%|
|Gross profit TTM||$125.6 million|
|Return on assets TTM||0.84%|
|Return on equity TTM||-7.63%|
|Market capitalisation||$423.9 million|
TTM: trailing 12 months
Shorting ANI Pharmaceuticals shares
There are currently 439,265 ANI Pharmaceuticals shares held short by investors – that's known as ANI Pharmaceuticals's "short interest". This figure is 11.9% down from 498,479 last month.
There are a few different ways that this level of interest in shorting ANI Pharmaceuticals shares can be evaluated.
ANI Pharmaceuticals's "short interest ratio" (SIR)
ANI Pharmaceuticals's "short interest ratio" (SIR) is the quantity of ANI Pharmaceuticals shares currently shorted divided by the average quantity of ANI Pharmaceuticals shares traded daily (recently around 66054.887218045). ANI Pharmaceuticals's SIR currently stands at 6.65. In other words for every 100,000 ANI Pharmaceuticals shares traded daily on the market, roughly 6650 shares are currently held short.
However ANI Pharmaceuticals's short interest can also be evaluated against the total number of ANI Pharmaceuticals shares, or, against the total number of tradable ANI Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ANI Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 ANI Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.048% of the tradable shares (for every 100,000 tradable ANI Pharmaceuticals shares, roughly 48 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ANI Pharmaceuticals.
Find out more about how you can short ANI Pharmaceuticals stock.
ANI Pharmaceuticals share dividends
We're not expecting ANI Pharmaceuticals to pay a dividend over the next 12 months.
Have ANI Pharmaceuticals's shares ever split?
ANI Pharmaceuticals's shares were split on a 1:6 basis on 17 July 2013. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ANI Pharmaceuticals shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for ANI Pharmaceuticals shares which in turn could have impacted ANI Pharmaceuticals's share price.
ANI Pharmaceuticals share price volatility
Over the last 12 months, ANI Pharmaceuticals's shares have ranged in value from as little as $23.55 up to $39.9999. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ANI Pharmaceuticals's is 1.2922. This would suggest that ANI Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ANI Pharmaceuticals overview
ANI Pharmaceuticals, Inc. , a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota. .
Stocks similar to ANI Pharmaceuticals
ANI Pharmaceuticals in the news
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
Frequently asked questionsWhat percentage of ANI Pharmaceuticals is owned by insiders or institutions?
Currently 5.031% of ANI Pharmaceuticals shares are held by insiders and 79.101% by institutions. How many people work for ANI Pharmaceuticals?
Latest data suggests 369 work at ANI Pharmaceuticals. When does the fiscal year end for ANI Pharmaceuticals?
ANI Pharmaceuticals's fiscal year ends in December. Where is ANI Pharmaceuticals based?
ANI Pharmaceuticals's address is: 210 Main Street West, Baudette, MN, United States, 56623 What is ANI Pharmaceuticals's ISIN number?
ANI Pharmaceuticals's international securities identification number is: US00182C1036 What is ANI Pharmaceuticals's CUSIP number?
ANI Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00182C103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert